GO:0045869 negative regulation of single stranded viral RNA replication via double stranded DNA intermediate

GO:0045869, negative regulation of single stranded viral RNA replication via double stranded DNA intermediate, is a Gene Ontology biological_process term that captures the cellular and viral mechanisms which suppress the replication of single-stranded viral RNA genomes that pass through a double-stranded DNA intermediate. This replication strategy is characteristic of retroviruses and pararetroviruses, including hepatitis B virus (HBV), where the viral RNA genome is reverse-transcribed into DNA within the viral capsid before integration or virion secretion. Understanding how this process is negatively regulated is essential for dissecting the molecular arms race between host restriction factors and viral replication machinery. The term is particularly relevant to virology and antiviral drug discovery because blocking the transition from single-stranded RNA to double-stranded DNA can prevent the formation of infectious virions. In HBV, a para-retrovirus, the secretion of genome-free virions has been explained by a single strand blocking model, in which the accumulation of single-stranded viral RNA or DNA intermediates interferes with proper capsid maturation and virion morphogenesis. This model highlights how negative regulation at the level of genome replication can have profound effects on viral spread. For researchers, GO:0045869 provides a standardized framework for annotating genes and pathways that restrict retroviral or pararetroviral replication. By integrating QuickGO definitions with experimental evidence from PubMed, this article outlines the mechanisms, key genes, disease associations, and CRISPR-based research methods relevant to this ontology term.

In simple terms, GO:0045869 refers to any biological process that slows down or stops the replication of a single-stranded viral RNA genome that must first be copied into double-stranded DNA before it can be replicated or packaged. This definition is derived from the QuickGO entry for GO:0045869, which states: Any process that stops, prevents, or reduces the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate. The term is classified under biological_process and includes synonyms such as down regulation of retroviral genome replication, inhibition of retroviral genome replication, and negative regulation of retroviral genome replication.

GO:0045869 is important because it defines a critical checkpoint in the replication of retroviruses and pararetroviruses, including hepatitis B virus, where the transition from single-stranded RNA to double-stranded DNA is tightly linked to capsid assembly and virion secretion. Negative regulation of this step can determine whether infected cells produce infectious virions or genome-free particles, directly influencing viral spread and pathogenesis. Understanding this process at the molecular level provides a foundation for developing antiviral strategies that target reverse transcription, capsid maturation, or genome packaging.

The following genes and proteins are involved in the replication and negative regulation of single-stranded viral RNA genomes that proceed through a double-stranded DNA intermediate, with a focus on hepatitis B virus as a model para-retrovirus.

The negative regulation of single stranded viral RNA replication via double stranded DNA intermediate is controlled by a complex interplay between viral and host factors. Host restriction factors such as APOBEC3G, SAMHD1, and SERINC proteins can directly inhibit reverse transcription or reduce the availability of nucleotides and lipids required for efficient DNA synthesis. Viral proteins, including the HBV polymerase and core protein, can counteract these restrictions by promoting capsid assembly and creating a protected environment for reverse transcription. Additionally, innate immune signaling pathways involving cGAS-STING and interferon-stimulated genes can upregulate restriction factors that suppress viral genome replication. The single strand blocking model further suggests that the accumulation of unprocessed nucleic acid intermediates can serve as a regulatory signal that prevents virion maturation and secretion.

Hepatitis B virus is a para-retrovirus that replicates its single-stranded RNA genome via a double-stranded DNA intermediate, and negative regulation of this process is directly relevant to the pathogenesis of chronic hepatitis B. The single strand blocking model explains how defects in genome maturation can lead to the secretion of genome-free virions, which may contribute to viral persistence and immune evasion. Chronic HBV infection is a major risk factor for cirrhosis and hepatocellular carcinoma, and understanding the regulatory mechanisms of genome replication can inform antiviral strategies.

Retroviruses such as HIV-1 also replicate through a double-stranded DNA intermediate, and host restriction factors that negatively regulate this step are critical determinants of viral tropism and disease progression. While the cited study focuses on HBV, the principles of single strand blocking and negative regulation are broadly applicable to retroviral replication. Experimental models that manipulate these regulatory pathways can help identify new targets for antiviral therapy.

The double-stranded DNA intermediates generated during retroviral and pararetroviral replication can be sensed by host innate immune receptors such as cGAS and IFI16, leading to interferon responses that further restrict viral replication. Negative regulation of single stranded viral RNA replication via double stranded DNA intermediate therefore intersects with innate immunity, and dysregulation of these pathways can contribute to immunopathology. Studying this crosstalk may reveal new therapeutic opportunities for chronic viral infections.

RNA-seq can quantify viral and host transcript levels during infection, revealing changes in single-stranded viral RNA accumulation and host gene expression that accompany negative regulation of replication. By comparing wild-type and knockout cells, researchers can identify host factors that restrict HBV or retroviral genome replication.

Mass spectrometry-based proteomics can identify viral and host proteins associated with capsids or reverse transcription complexes, providing insights into the molecular machinery that mediates negative regulation. Affinity purification of tagged viral proteins followed by proteomics can reveal interaction partners that influence single strand blocking.

Fluorescence microscopy and single-molecule imaging can visualize the localization and dynamics of viral RNA and DNA intermediates within infected cells, helping to test the single strand blocking model. These methods can reveal whether negative regulators prevent the formation of double-stranded DNA or promote the accumulation of stalled intermediates.

Genome-wide CRISPR knockout or activation screens can systematically identify host genes that negatively regulate single stranded viral RNA replication via double stranded DNA intermediate. Hits from these screens can be validated with targeted knockouts or overexpression models and further studied using bioinformatics pathway analysis.

Researchers studying negative regulation of single stranded viral RNA replication via double stranded DNA intermediate-related genes often need to determine whether a candidate gene is causally involved in restricting viral replication or is merely correlated with the phenotype. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to enable such causal studies, from knockout and point-mutation to knock-in and overexpression, as well as library screening and bioinformatics support.

GO:0045869, negative regulation of single stranded viral RNA replication via double stranded DNA intermediate, is a biologically and clinically significant ontology term that captures the mechanisms restricting a key step in the replication of retroviruses and pararetroviruses such as hepatitis B virus. The single strand blocking model provides a mechanistic framework for understanding how incomplete reverse transcription leads to genome-free virion secretion and reduced infectivity. By leveraging CRISPR-based knockout, point-mutation, knock-in, and overexpression models, along with library screening and bioinformatics, researchers can systematically dissect the host and viral factors that control this process. Such studies may reveal new targets for antiviral therapy and improve our understanding of viral persistence and disease progression.